PURE Bioscience (OTCMKTS:PURE – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.06 and traded as high as $0.0698. PURE Bioscience shares last traded at $0.0556, with a volume of 96,288 shares.
PURE Bioscience Trading Down 11.3%
The stock has a market cap of $7.23 million, a P/E ratio of -1.85 and a beta of 0.22. The firm’s fifty day moving average is $0.07 and its 200 day moving average is $0.06.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last released its earnings results on Monday, June 15th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.51 million for the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Featured Stories
- Five stocks we like better than PURE Bioscience
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
